Current Assets

Neurocrine Biosciences·Balance Sheet Statement·17 metrics

Breakdown

Loading...

Metrics

AFS and Trading Securities - Unrealized Loss Position Fair Value

Cash and cash equivalents

Cash, Cash Equivalents, and Marketable Securities

Available For Sale Securities Debt Securities Current

Other current assets

Income taxes receivable

Finished goods

Raw materials

Work in process

Operating Lease Income - 2022 (Lessor)

Operating Lease Income - 2025 (Lessor)

Operating Lease Receivables (Current)

Other Inventory, Net

Prepaid expenses and other current assets

Restricted cash

Short-term investments

Total current assets